These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7811060)

  • 1. In vitro inhibition of human cytomegalovirus replication by desferrioxamine.
    Cinatl J; Cinatl J; Rabenau H; Gümbel HO; Kornhuber B; Doerr HW
    Antiviral Res; 1994 Sep; 25(1):73-7. PubMed ID: 7811060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro inhibition of human cytomegalovirus replication by calcium trinatrium diethylenetriaminepentaacetic acid.
    Cinatl J; Hoffmann F; Cinatl J; Weber B; Scholz M; Rabenau H; Stieneker F; Kabickova H; Blasko M; Doerr HW
    Antiviral Res; 1996 Jun; 31(1-2):23-34. PubMed ID: 8793006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of desferrioxamine on human cytomegalovirus replication and expression of HLA antigens and adhesion molecules in human vascular endothelial cells.
    Cinatl J; Scholz M; Weber B; Cinatl J; Rabenau H; Markus BH; Encke A; Doerr HW
    Transpl Immunol; 1995 Dec; 3(4):313-20. PubMed ID: 8665150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Selective inhibition of replication of human cytomegalovirus by desferrioxamine in vitro and in vivo (case report)].
    Gümbel H; Cinatl J; Rabenau H; Vogel JU; Doerr HW; Ohrloff C
    Ophthalmologe; 1995 Dec; 92(6):840-3. PubMed ID: 8563434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of desferrioxamine (DFO) and calcium trinatrium diethylenetriaminepentaacetic acid (DTPA) on rat cytomegalovirus replication in vitro and in vivo.
    Kloover JS; Scholz M; Cinatl J; Lautenschlager I; Grauls GE; Bruggeman CA
    Antiviral Res; 1999 Nov; 44(1):55-65. PubMed ID: 10588333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral and immunomodulatory effects of desferrioxamine in cytomegalovirus-infected rat liver allografts with rejection.
    Martelius T; Scholz M; Krogerus L; Höckerstedt K; Loginov R; Bruggeman C; Cinatl J; Doerr HW; Lautenschlager I
    Transplantation; 1999 Dec; 68(11):1753-61. PubMed ID: 10609953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro inhibition of human cytomegalovirus replication in human foreskin fibroblasts and endothelial cells by ascorbic acid 2-phosphate.
    Cinatl J; Cinatl J; Weber B; Rabenau H; Gümbel HO; Chenot JF; Scholz M; Encke A; Doerr HW
    Antiviral Res; 1995 Aug; 27(4):405-18. PubMed ID: 8540759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of human cytomegalovirus immediate-early gene expression and replication by the ethyl acetate (EtOAc) fraction of Elaeocarpus sylvestris in vitro.
    Bae S; Kang SC; Song YJ
    BMC Complement Altern Med; 2017 Aug; 17(1):428. PubMed ID: 28851336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The extract of Elaeocarpus sylvestris inhibits human cytomegalovirus immediate early gene expression and replication in vitro.
    To KP; Kang SC; Song YJ
    Mol Med Rep; 2014 Feb; 9(2):744-8. PubMed ID: 24270403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effect of hexamethylene bisacetamide on replication of human cytomegalovirus.
    Kitagawa R; Hagihara K; Uhara M; Matsutani K; Kirita A; Tanaka J
    Arch Virol; 2005 Oct; 150(10):1977-91. PubMed ID: 15959837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Natural Flavonoid Compound Deguelin Inhibits HCMV Lytic Replication within Fibroblasts.
    Nukui M; O'Connor CM; Murphy EA
    Viruses; 2018 Nov; 10(11):. PubMed ID: 30405048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppressive dose of azathioprine inhibits replication of human cytomegalovirus in vitro.
    Shiraki K; Ishibashi M; Okuno T; Namazue J; Yamanishi K; Sonoda T; Takahashi M
    Arch Virol; 1991; 117(3-4):165-71. PubMed ID: 1850228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of short-chain fatty acids on the susceptibility of human umbilical vein endothelial cells to human cytomegalovirus infection.
    Wu QH; Ascensao J; Almeida G; Forman SJ; Shanley JD
    J Virol Methods; 1994 Apr; 47(1-2):37-50. PubMed ID: 8051232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Thrombopoietin Receptor Agonist Eltrombopag Inhibits Human Cytomegalovirus Replication Via Iron Chelation.
    Vogel JU; Schmidt S; Schmidt D; Rothweiler F; Koch B; Baer P; Rabenau H; Michel D; Stamminger T; Michaelis M; Cinatl J
    Cells; 2019 Dec; 9(1):. PubMed ID: 31861948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of the iron(III) chelator, desferrioxamine, on iron and transferrin uptake by the human malignant melanoma cell.
    Richardson D; Ponka P; Baker E
    Cancer Res; 1994 Feb; 54(3):685-9. PubMed ID: 8306330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel chemical class of pUL97 protein kinase-specific inhibitors with strong anticytomegaloviral activity.
    Herget T; Freitag M; Morbitzer M; Kupfer R; Stamminger T; Marschall M
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4154-62. PubMed ID: 15504835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of ganciclovir-resistant human cytomegalovirus replication by Kampo (Japanese herbal medicine).
    Murayama T; Yamaguchi N; Iwamoto K; Eizuru Y
    Antivir Chem Chemother; 2006; 17(1):11-6. PubMed ID: 16542001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human cytomegalovirus replicates in gamma-irradiated fibroblasts.
    Shanley JD
    J Med Virol; 1986 Dec; 20(4):347-55. PubMed ID: 3025353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of desferrioxamine on normal and leukemic human hematopoietic cell growth: in vitro and in vivo studies.
    Dezza L; Cazzola M; Danova M; Carlo-Stella C; Bergamaschi G; Brugnatelli S; Invernizzi R; Mazzini G; Riccardi A; Ascari E
    Leukemia; 1989 Feb; 3(2):104-7. PubMed ID: 2911202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased human cytomegalovirus replication in fibroblasts after treatment with therapeutical plasma concentrations of valproic acid.
    Michaelis M; Köhler N; Reinisch A; Eikel D; Gravemann U; Doerr HW; Nau H; Cinatl J
    Biochem Pharmacol; 2004 Aug; 68(3):531-8. PubMed ID: 15242819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.